Código QR (código de barras bidimensional)

Emicizumab in the Treatment of Hemophilia A. Characteristics and clinical application

Introduction: Hemophilia A is an inherited bleeding disorder caused by a congenital deficiency of factor VIII. It is characterized by a tendency for prolonged and excessive bleeding, both spontaneous and trauma-induced. The treatment of hemophilia A involves the use of factor VIII replacement thera...

ver descrição completa

Na minha lista:
Principais autores: Ilona Bednarek, Sylwia Lach, Aleksandra Kowalczyk, Adrian Pączek, Paweł Dyczek, Julia Hofman, Wiktoria Staniszewska, Olaf Jadanowski, Karol Seweryn Błąd
Formato: Artigo
Idioma:Inglês
Publicado em: Kazimierz Wielki University 2025-11-01
coleção:Journal of Education, Health and Sport
Assuntos:
Hemophilia A
emicizumab
pharmacokinetics
ABR
HAVEN trials
factor VIII
Acesso em linha:https://apcz.umk.pl/JEHS/article/view/66759
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados